-

McKesson Announces Bansi Nagji to Step Down as Executive Vice President, Chief Strategy and Business Development Officer

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announced that Bansi Nagji, executive vice president and chief strategy and business development officer, will step down from his role effective March 31, 2020. Mr. Nagji has agreed to continue employment with the company for several weeks to assist with transition activities. McKesson is currently conducting a comprehensive search and expects to name Nagji’s successor within the next few months.

“For the past five years, Bansi has been a critical member of our executive team and has played an important role in key acquisitions and the evolution of our strategy to reposition McKesson in a rapidly-evolving market,” said Brian Tyler, Chief Executive Officer, McKesson. “We are grateful for his many contributions which have strengthened our core business and created new areas of growth. With the recent completion of our successful exit from Change Healthcare, and in the context of the company’s headquarters move to Dallas, Bansi and I agreed that this was the right time for this transition. We appreciate Bansi’s commitment to remain with the company for an interim period to assist with the transition of his responsibilities and wish him all the best as he begins his successful next chapter.”

Prior to joining McKesson in 2015, Nagji served as a principal of Deloitte Consulting, LLP where he led the U.S. Strategy Service Line and the Global practice of Monitor Deloitte, which was formed by the global merger of Monitor Group with Deloitte in January 2013. He was instrumental in the integration of Monitor into Deloitte’s operations. Before the merger with Deloitte, Nagji was president of Monitor Group. Nagji has served on several boards, including Change Healthcare, Inc.

About McKesson Corporation

McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients. McKesson has been named the “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.

Contacts

Holly Weiss, 972-969-9174 (Investors)
Holly.Weiss@McKesson.com
David Matthews, 214-952-0833 (Media)
David.Matthews@McKesson.com

McKesson Corporation

NYSE:MCK

Release Versions

Contacts

Holly Weiss, 972-969-9174 (Investors)
Holly.Weiss@McKesson.com
David Matthews, 214-952-0833 (Media)
David.Matthews@McKesson.com

More News From McKesson Corporation

McKesson Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth Targets

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 fourth quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 7, at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and arch...

McKesson Corporation Declares Quarterly Dividend

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on July 1, 2026, to shareholders of record on June 1, 2026. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers,...

McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK), a leading Healthcare Services company, today announced it has entered into a definitive agreement with funds managed by affiliates of Apollo (“Apollo Funds”), under which Apollo Funds will acquire a minority ownership interest in McKesson’s Medical-Surgical Solutions (“MMS”) business. This transaction represents a meaningful milestone as McKesson executes its separation strategy of MMS in preparation of a planned initial public o...
Back to Newsroom